 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Bulletin of Experimental Treatments for AIDS
|
Email
Print-Friendly
Glossary
PDF |
By Liz Highleyman
By Liz Highleyman
Departments
-
News Briefs: Conference Coverage
By Liz Highleyman -
Policy and Politics: Medicare Prescription Drug Coverage -- Preparing for January 1, 2006
By Jeffrey S. Crowley, M.P.H. -
Drug Watch: Pipeline Progress -- Then and Now
By John Hawes -
Women and HIV: Women's Research Roundup
By Kristen Jill Kresge - Open Clinical Trials for HIV/AIDS Treatments
News Flash
On July 1, as BETA went to press, Pfizer announced that it would stop clinical development of capravirine. Recent research showed that this experimental NNRTI did not offer a significant improvement over existing treatments, and that use of capravirine would likely be hampered by interactions with other anti-HIV therapies.
Notice
The statements and opinions in BETA are published as an educational resource only, and do not imply recommendation or endorsement by BETA or the San Francisco AIDS Foundation. Always consult a physician before taking any drug or changing a drug regimen.
|
Bulletin of Experimental Treatments for AIDS Editorial Staff:
Scientific Advisory Committee: George Beatty, M.D., M.P.H.; Lisa Capaldini, M.D.; Eric Goosby, M.D.; Cristina Gruta, Pharm.D.; Gregory Pauxtis, M.D.; Joanna Rinaldi; John Stansell, M.D.; Paul Wisotsky Copyright Editorial office and mailing address: |
This article was provided by San Francisco AIDS Foundation. It is a part of the publication Bulletin of Experimental Treatments for AIDS. Visit San Francisco AIDS Foundation's Web site to find out more about their activities, publications and services.
 |
 |
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
